There is limited data from long-term prospective studies on the natural course of metabolic syndrome (MetS) incidence in healthy obese phenotypes. The aim of this study was to determine the incidence and predictors of the MetS in healthy obese subjects without the MetS at baseline after a decade of follow-up. SUBJECTS/METHODS: In this prospective cohort study, 438 obese subjects free from MetS at baseline, aged X20 years, were selected from among the participants of the Tehran Lipid and Glucose Study and followed up for 10 years for development of MetS. Based on national data, central obesity was defined as waist circumference cutoff point of 89 cm for men and 91 cm for women. RESULTS: Initially, subjects had a mean age of 41.1 ± 11.8 years and a body mass index of 32.7 ± 2.7 kg/m 2 . At the end of follow-up, the cumulative incidence (95% confidence interval) of MetS was 44.0 (36.8-51.1)%. In the multivariable analysis, the adjusted odds ratios of hypertension, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C) and insulin resistance for the development of MetS were 3.08 (1.39-6.79), 2.84 (1.26-6.42), 6.49 (3.18-13.25) and 2.87 (1.55-5.32), respectively. The area under receiver operating characteristic curve of all the components was significantly higher than various combinations of MetS components, except for the two models including combinations of three components, that is, triglycerides (TGs), HDL-C and fasting blood sugar, as well as, TGs, HDL-C and systolic blood pressure. CONCLUSIONS: Our findings demonstrate that MetS developed in nearly half of the individuals during the 10 years of follow-up. Predictors of MetS in healthy obese subjects may differ from the general population, and waist circumference does not have an independent role.
INTRODUCTION
Obesity, one of the most significant and rapidly increasing public health burdens worldwide, is accompanied with various risks of metabolic and cardiovascular complications. 1 With a recent upward trend of overweight and obesity, it is projected that by 2030 up to 57.8% people of the world's adult population could be either overweight or obese. 2 Two well-known phenotypes of obesity have been described in medical literature, that is, 'Metabolically obese but normal weight' (MONW) and 'metabolically healthy but obese' (MHO). 3 MHO are a unique subset of obese individuals, who despite having excessive body fatness, exhibit favorable metabolic profiles, including high levels of insulin sensitivity, no hypertension as well as normal lipid, inflammation, hormonal and immune profiles. 4, 5 Among American adults in the National Health and Nutrition Examination Survey (NHANES; 1999-2004), 23 .5% of normal weight adults were metabolically abnormal, whereas 51.3% of overweight adults and 31.7% of obese adults were metabolically healthy. 6 A recent study in Tehranian adults, aged X40 years shows that 12.5% of normal weight and 24.0% of obese subjects had MONW and MHO phenotypes, respectively. 7 Furthermore, as seen in different studies, subjects with the MHO phenotype seems to be less susceptible to cardiovascular disease than the MNOW phenotype. [7] [8] [9] However, some studies with 415-year follow-ups reported an increased risk of metabolic syndrome (MetS) incidence, which may be explained by developing of MetS over a longer follow-up period. 10 In fact, the natural course of MetS incidence in healthy obese phenotypes has not been investigated in long-term prospective studies. 11, 12 Several studies indicate that predictors of the MetS vary in different populations despite various definitions of MetS. [13] [14] [15] [16] In general populations, central adiposity (in the United States and Spain); 17 waist circumference (WC), high-density lipoprotein (HDL) cholesterol (HDL-C) and triglycerides (TGs) (in China); 16 and WC, HDL-C and pro-insulin (in Whites, Blacks and Hispanics) 14 were all major determinants of MetS. Moreover, in our previous study, conducted in Tehranian adults, WC, plasma HDL and TGs predicted the development of MetS better than hypertension and hyperglycemia. 15 However, only a few cross-sectional studies specifically address predictors of the MetS in obese individuals; for instance, a study which compared obese subjects with the general population reported that the most important of predictors of MetS were fasting TG, HDL-C and insulinemia, as well as, insulin sensitivity, indicating different predictors. 18 Considering the high prevalence of MetS in Iranian populations, 19, 20 and the limited data available on the major contributors of MetS in healthy obese persons, this study aimed at determining the incidence and predictors of MetS in obese subjects without MetS initially during a 10-year follow-up in a prospective cohort of an Iranian population.
MATERIALS AND METHODS Subjects
This prospective study was conducted within the framework of the Tehran Lipid and Glucose Study (TLGS), a population-based study conducted on a representative sample of residents of district-13 of Tehran, with the aim of determining the prevalence of non-communicable disease risk factors and developing a healthy lifestyle to improve these risk factors. In the TLGS, 15 005 individuals, aged X3 years and living in the district-13 of Tehran, were selected by multistage cluster random sampling methods; we excluded those with a history of significant hepatic, renal or thyroid dysfunction, acute or chronic inflammatory diseases, recent surgical operations, myocardial infarction or a cerebro-vascular incident within the previous 3 months, corticosteroid medication, pregnancy and normal weight and overweight subjects with MetS. Of the 10 386 subjects, aged X20 years, who participated in the first phase of TLGS (1999) (2000) (2001) , 2283 (23%) subjects were obese, based on body mass indices (BMIs) X30 kg/m 2 . After exclusion of 1628 (71%) obese subjects with MetS at baseline, 46 (2%) participants who had missing data and 217 (33%) who were lost to followup, 438 obese without MetS (85 males and 353 females) with complete 10-year follow-ups remained for the current analysis.
Methods
Subjects were interviewed privately, face to face by trained interviewers using pre-tested questionnaires. Initially, information on age, family history of diabetes and medication use was collected. Physical activity level was assessed using a Lipid Research Clinic questionnaire 21 in the first phase of the TLGS. Severe physical activity was defined as exercise or physical activity at least three times a week, moderate physical activity as exercise or physical activity less than three times a week and inactive individuals were those who had no exercise or physical activity in the past week.
Weight was measured with subjects minimally clothed without shoes, using digital scales and recorded to the nearest 100 g. Height was measured with subjects in a standing position without shoes, using a tape meter, with the shoulders in a normal state. BMI was calculated as weight in kilograms divided by height in meters squared. WC was measured at the level of the umbilicus using an un-stretched tape meter, without any pressure to the body surface, and was recorded to the nearest 0.1 cm. All measurements were taken by the same person. To measure blood pressure, subjects were first asked to rest for 15 min, when a qualified physician took the systolic blood pressure (SBP) and diastolic blood pressure twice in a seated position, after one initial measurement for determining the peak inflation level using a standard mercury sphygmomanometer (Riester Sphygmomanometer, Tuttlingen, Germany). There was at least a 30-s interval between these two separate measurements; thereafter, the mean of the two measurements was considered to be the participant's blood pressure.
A blood sample was drawn from all the study participants after fasting 12-14 h overnight, and all the blood sample analyses were undertaken at the TLGS research laboratory on the day of blood collection, using selectra 2 auto-analyzer (Vital Scientific, Spankeren, the Netherlands). Fasting blood sugar (FBS) was measured by the enzymatic colorimetric method using glucose oxidase. For lipid measurements, total cholesterol and TG levels were assayed by relevant kits (Pars Azmoun, Tehran, Iran) using enzymatic colorimetric tests with cholesterol esterase and cholesterol oxidase, and glycerol phosphate oxidase, respectively. HDL-C was measured with phosphotungstic acid. All samples were analyzed when internal quality control met the acceptable criteria. Inter-and intra-assay coefficients of variations at baseline were both 2.2% for serum glucose, 2% and 0.5% for HDL-C and 1.6% and 0.6% for TG, respectively. Insulin concentration was measured using the enzyme-linked immunosorbent assay (Mercodia, Uppsala, Sweden) with inter-and intra-assay coefficients of variation 3.3% and 1.4%, respectively.
Definition of terms
MetS was defined with the criteria proposed by a Joint Interim Statement (JIS). 22 According to the JIS definition, the presence of any three of the five risk factors of the following: (1) abdominal obesity as WC cutoff point of 89 cm for men and 91 cm for women, based on national data; 19 (2) FBS X100 mg/dl or 2-h blood glucose X140 mg/dl or drug treatment; (3) fasting TGs X150 mg/dl or drug treatment; (4) fasting HDLCo50 mg/dl in women and o40 mg/dl in men or drug treatment; (5) raised blood pressure defined as SBP X130 mm Hg, diastolic blood pressure X85 mm Hg or antihypertensive drug treatment. Insulin resistance (IR) was evaluated by the homeostasis model assessmentinsulin resistance (HOMA-IR) index, calculated using the following equation: HOMA-IR ¼ fasting insulin (mU/l) Â fasting glucose (mmol/l)/ 22.5. 23 To determine the IR cutoff point, 80 subjects with BMI 18.5-25 kg/m 2 , FBS o100 mg/dl and 2 h post-glucose load (2 h-PG) o140 mg/dl and aged 25-84 years (mean ± s.d. age 45.3 ± 15.5 years) were selected in whom HOMA-IR distribution had some skewness and the 95th percentile was considered for definition of IR (2.50 mol Â mU/l 2 ). 24 Interventional strategies, based on lifestyle modifications in diet, smoking and physical activity, were implemented through face-to-face education, leaflets and brochures, school programs, training volunteers as health teams and treating patients with noncommunicable disease risk factors in 5630 subjects; 9375 individuals served as controls in the TLGS. 25 
Statistical analysis
Continuous variables and categorical variables were presented as mean ± s.d. and percentages, respectively. Chi-square and Mann-Whitney or t-tests were used to assess the significance of differences for categorical and continuous variables in the baseline characteristics of subjects with and without MetS at follow-up, respectively. The dichotomous variables, that is, abdominal obesity, FBS 4100 mg/dl, hypertension, hypertriglyceridemia, low HDL-C and IR are considered as the metabolic predictors. Multivariable logistic regression with backward stepwise method was used to estimate the adjusted odds ratios and 95% confidence intervals of the different components after adjustment of relevant confounders, that is, age (year), smoking (yes/no), physical activity (light/moderate/heavy) and intervention (yes/no), for prediction of the MetS. Model calibration was assessed with the Hosmer-Lemenshow test of goodness of fit; statistically significant chi-square statistic from this test indicates a poor model fit. The receiver operating characteristic curve was calculated for various combinations of MetS components after adjusting for age, smoking, physical activity and intervention. Statistical analyses were done using the SPSS 16.0 statistical software package (SPSS, Chicago, IL, USA). The statistical significance of differences between the curves was assessed using STATA software package version 10.0 (Stata Corporation, College Station, TX, USA) according to the algorithm developed by Delong et al., 26 with P values o0.05 being considered significant.
RESULTS
In this prospective cohort study, a metabolically healthy phenotype was observed in 28.7% of obese subjects. Four hundred and thirty-eight subjects initially without MetS (81% female) with a mean age of 41.1 ± 11.8 years and BMI of 32.7 ± 2.7 kg/m 2 were followed up for the development of MetS. The characteristics of obese subjects according to their MetS status at follow-up are shown in Table 1 . As compared with obese subjects without MetS, those who developed MetS were significantly older and had higher TGs, SBP, FBS, 2-h blood glucose, HOMA-IR, larger WC and lower HDL-C (Po0.05); no significant differences were observed in weight (P ¼ 0.469) and BMI (P ¼ 0.164). After a mean interval of 10 years, the cumulative incidence (95% confidence interval) of MetS was 44.0 (36.8-51.1)% in obese subjects free from MetS at baseline. Incidence of MetS in insulin-resistant subjects was significantly higher than those without IR, 57% vs 37%, respectively (P ¼ 0.002).
After adjustment for relevant confounders, hypertriglyceridemia, low HDL-C and IR were significant independent predictors for the development of MetS. However, multivariable analysisadjusted odds ratios of hypertension, hypertriglyceridemia, low HDL-C and IR were 3.08 (1. Table 2 ). The area under receiver operating characteristic curves for predicting MetS when all components of the MetS used as continuous variables was 0.75 (0.70-0.80). The area under receiver operating characteristic curve of all components was significantly higher than various combinations of MetS components; however, no statistically significant difference was observed in the predictability of two models including combinations of the three components, that is, hypertriglyceridemia, low HDL-C and FBS Multivariable analysis was run with backward stepwise method; adjusted for age, smoking, physical activity, intervention, central obesity, hypertension, FBS 4100 mg/dl, hypertriglyceridemia, low HDL-C and insulin resistance. (Table 3) .
DISCUSSION
The present study investigated the incidence and predictors of MetS for the first time in obese subjects without MetS in Middle Eastern population during a decade of follow-up. Our results indicated a cumulative incidence of MetS of 44.0% in these obese individuals, initially without MetS, an incidence observed more in insulin-resistant subjects. Moreover, we found that after adjustment of relevant confounders, hypertriglyceridemia, low HDL-C and IR have independent predictive values for the development of MetS in the healthy obese. However, models that included combinations of TG, HDL-C and FBS and TG, HDL-C and SBP predicted MetS similarly to all five MetS components.
Metabolically healthy obesity is characterized by the absence of any overt cardiovascular disorders, especially hypertension, type 2 diabetes and dyslipidemia, and also cardiometabolic risk factors, for instance, MetS components and inflammatory markers in spite of BMIX30 kg/m 2 . When reviewing literature, there is no uniform definition for metabolic normality, [3] [4] [5] and due to criteria selected with different cutoff points for definition of MetS, the metabolic normality incidence in general and obese populations varies widely; 12 consequently, the comparison of different studies would be difficult. Moreover, the natural course of cardiometabolic abnormality in those healthy obese has not yet been elucidated over long-term follow-ups. 12, 27 In this relatively long-term study, the higher incidence of MetS in insulin-resistant subjects (57% vs 37%) can be regarded as a supporting evidence for inclusion of insulin sensitivity as a main criterion to define MHO. 12, 18 In our previous study conducted in a general population with mean interval of 6.5 years of follow-up, 20% and 26% incidences were reported for the development of MetS by the Adult Treatment Panel III and the International Diabetes Federation criteria, respectively. 15 In the present study, we found that MetS, by JIS definition, developed in nearly half of the obese subjects without MetS during 10 years of follow-up. There are controversial findings regarding the independent role of obesity in the development of cardiovascular disease and all-cause mortality. Some studies have shown that obesity, regardless of the presence or absence of MetS and IR, was associated with a higher risk for cardiometabolic comorbidities; 27 however, others have demonstrated that BMI and other anthropometric indices, whether assessed singly or in combination, do not significantly improve cardiovascular disease risk prediction when additional information is available for SBP, history of diabetes and lipids. 28 It is important to note that in contrast to short-term follow-up studies indicating lack of association between MHO and cardiovascular disease, 27 an increased risk has been observed by studies using longer follow-up periods. 10 One reason for the above mentioned inconsistency can be attributed to occurrence of metabolic abnormalities as demonstrated in our analysis, only during long-term follow-up. 8, 10 The predictive power of MetS components for the development of MetS varies in different populations. Different studies, including our previous one, conducted in general populations have revealed that WC, HDL-C and TGs are pivotal predictors of MetS development. 13, 15, 16 In the present study, multivariable analysis showed that hypertension, hypertriglyceridemia, low HDL-C and IR are independent predictors of MetS in the healthy obese subjects. Interestingly, our finding indicated that WC is a poor predictor of MetS in healthy obese which is in agreement with the findings by Stefan et al. 29 that demonstrated WC to be a powerful indicator in distinguishing between insulin sensitivity and IR, especially among normal weight and overweight subjects; however, it has a relatively weak predictive effect in obese subjects. Accordingly, some combinations of three elements of MetS, that is, 'HDL-C, TG and FBS' and 'HDL-C, TG and SBP' have discriminating powers similar to those of all the combined components. Some studies, although conducted in general populations, reported that a combination of two or three components, including WC, had as good predictive power as whole components. 15, 16 This study does have a few limitations; first, 30% of the participants of the baseline cohort study were excluded from analysis due to loss at follow-up; however, this group was similar in their baseline characteristic assessments (data not shown). Second, the physical activity level of subjects was evaluated with the quantitative Lipid Research Clinic questionnaire, which although simple and being completed using participants' oral responses, has not been validated in Iran. Third, we did not take into account socioeconomic status and nutritional factors in our analysis, and fourth, insulin concentration was measured in only 282 (64.4%) subjects.
In spite of the above mentioned limitations, the present study has its strengths. First, it is one of the few population-based studies with a relatively long-term follow-up to determine the predictors of MetS in healthy obese individuals in Middle East countries. Second, we used actual measurements of anthropometric parameters, rather than self-reported data. Third, we compared the predictive ability of all individual components and also a combination of components by using receiver operating characteristic curve analysis with adjustment of important confounding variables.
In conclusion, our results indicate a high incidence of MetS during a decade of follow-up in healthy obese subjects initially without MetS. The lower incidence of MetS in insulin-sensitive obese persons highlights the importance of inclusion of IR in the definition of the MHO phenotype. Moreover, serious questions have been raised over the role of WC as an independent predictor for MetS development in healthy obese subjects.
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